Justin Keywood
Stock Analyst at Stifel Nicolaus
(2.27)
# 2,765
Out of 5,055 analysts
932
Total ratings
50.5%
Success rate
0.3%
Average return
Main Sectors:
Stocks Rated by Justin Keywood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSXV: WSTR WELLSTAR Technologies Corp. | Reiterated: Buy | $10.00 | $6.55 | +52.67% | 1 | Oct 14, 2026 | |
| TSX: DHT.UN DRI Healthcare Trust | Reiterated: Buy | $26.00 → $27.00 | $17.98 | +50.17% | 48 | Sep 29, 2026 | |
| TSX: WELL WELL Health Technologies Corp. | Reiterated: Buy | $8.50 | $4.14 | +105.31% | 159 | Sep 29, 2026 | |
| TSX: CPH Cipher Pharmaceuticals Inc. | Reiterated: Buy | $20.00 | $13.35 | +49.81% | 41 | Sep 23, 2026 | |
| TSX: APTX Apotex Health Corp. | Reiterated: Buy | $42.00 | $30.65 | +37.03% | 4 | Sep 21, 2026 | |
| TSXV: NPTH NeuPath Health Inc. | Reiterated: Buy | $0.58 → $0.68 | $0.58 | +17.24% | 10 | Sep 16, 2026 | |
| TSX: ATS ATS Corporation | Reiterated: Buy | $44.00 | $24.65 | +78.50% | 136 | Sep 15, 2026 | |
| TSX: SIS Savaria Corporation | Reiterated: Buy | $35.00 | $29.53 | +18.52% | 65 | Sep 15, 2026 | |
| TSX: CHLT Custom Health Holdings Inc. | Reiterated: Buy | $12.00 | $7.25 | +65.52% | 5 | Sep 11, 2026 | |
| TSX: HLS HLS Therapeutics Inc. | Reiterated: Hold | $4.45 | $4.10 | +8.54% | 103 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.50 → $2.25 | $0.68 | +230.88% | 22 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.45 → $11.00 | $10.61 | +3.68% | 54 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $45.00 → $45.75 | $45.46 | +0.64% | 51 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11.00 | $7.29 | +50.89% | 10 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.96 | $232.17 | -97.43% | 2 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4.50 | $3.25 | +38.46% | 42 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50.00 → $52.00 | $41.06 | +26.64% | 60 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $1.57 | +283.39% | 14 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1.76 | $0.3131 | +461.88% | 1 | Mar 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $1.50 | $0.50 | +200.00% | 4 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6.00 → $3.45 | $4.83 | n/a | 47 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.25 | n/a | 12 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.28 | n/a | 5 | Apr 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.18 | n/a | 5 | May 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.135 | n/a | 5 | May 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $64.51 | n/a | 17 | May 17, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $37.65 | n/a | 6 | May 17, 2019 |
WELLSTAR Technologies Corp.
Oct 14, 2026
Reiterated: Buy
Price Target: $10.00
Current: $6.55
Upside: +52.67%
DRI Healthcare Trust
Sep 29, 2026
Reiterated: Buy
Price Target: $26.00 → $27.00
Current: $17.98
Upside: +50.17%
WELL Health Technologies Corp.
Sep 29, 2026
Reiterated: Buy
Price Target: $8.50
Current: $4.14
Upside: +105.31%
Cipher Pharmaceuticals Inc.
Sep 23, 2026
Reiterated: Buy
Price Target: $20.00
Current: $13.35
Upside: +49.81%
Apotex Health Corp.
Sep 21, 2026
Reiterated: Buy
Price Target: $42.00
Current: $30.65
Upside: +37.03%
NeuPath Health Inc.
Sep 16, 2026
Reiterated: Buy
Price Target: $0.58 → $0.68
Current: $0.58
Upside: +17.24%
ATS Corporation
Sep 15, 2026
Reiterated: Buy
Price Target: $44.00
Current: $24.65
Upside: +78.50%
Savaria Corporation
Sep 15, 2026
Reiterated: Buy
Price Target: $35.00
Current: $29.53
Upside: +18.52%
Custom Health Holdings Inc.
Sep 11, 2026
Reiterated: Buy
Price Target: $12.00
Current: $7.25
Upside: +65.52%
HLS Therapeutics Inc.
Aug 14, 2026
Reiterated: Hold
Price Target: $4.45
Current: $4.10
Upside: +8.54%
Aug 10, 2026
Reiterated: Buy
Price Target: $2.50 → $2.25
Current: $0.68
Upside: +230.88%
Aug 7, 2026
Reiterated: Buy
Price Target: $7.45 → $11.00
Current: $10.61
Upside: +3.68%
Aug 7, 2026
Downgraded: Hold
Price Target: $45.00 → $45.75
Current: $45.46
Upside: +0.64%
Aug 7, 2026
Reiterated: Buy
Price Target: $11.00
Current: $7.29
Upside: +50.89%
Aug 5, 2026
Reiterated: Buy
Price Target: $5.96
Current: $232.17
Upside: -97.43%
Jul 31, 2026
Reiterated: Buy
Price Target: $4.50
Current: $3.25
Upside: +38.46%
Jul 31, 2026
Reiterated: Buy
Price Target: $50.00 → $52.00
Current: $41.06
Upside: +26.64%
May 21, 2026
Reiterated: Buy
Price Target: $6
Current: $1.57
Upside: +283.39%
Mar 20, 2026
Reiterated: Buy
Price Target: $1.76
Current: $0.3131
Upside: +461.88%
Dec 12, 2025
Initiated Coverage: Buy
Price Target: $1.50
Current: $0.50
Upside: +200.00%
Feb 6, 2025
Downgraded: Hold
Price Target: $6.00 → $3.45
Current: $4.83
Upside: n/a
Apr 28, 2023
Rated: Hold
Price Target: n/a
Current: $0.25
Upside: n/a
Apr 3, 2020
Rated: Hold
Price Target: n/a
Current: $1.28
Upside: n/a
Dec 6, 2019
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $4.18
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $0.135
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $64.51
Upside: n/a
May 17, 2019
Rated: Hold
Price Target: n/a
Current: $37.65
Upside: n/a